# Valproate and Levocarnitine in Children With Spinal Muscular Atrophy

> **NCT01671384** · PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Spinal Muscular Atrophy

## Interventions

- **DRUG:** Valproate, Levocarnitine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01671384
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01671384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01671384, "Valproate and Levocarnitine in Children With Spinal Muscular Atrophy". Retrieved via MORVS 2026-10-13 from https://api.morvs.ai/clinical/NCT01671384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*